During the past decade, Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut" #1 collaborator was "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator, "Seagen Inc." with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut" are "Cachexia; Cancer" (1 trials), "Gastric Cancer" (1 trials), "Hodgkin's Disease" (1 trials), "Non Small Cell Lung Cancer" (1 trials) and "Relapsed or Refractory Multiple Myeloma" (1 trials). Many other conditions were trialed in "Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut" in a lesser frequency.

Most popular intervention types in "Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut" are "Drug" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Anamorelin Hydrochloride" (1 trials), "Bemarituzumab" (1 trials), "Brentuximab vedotin" (1 trials), "Carfilzomib" (1 trials) and "Dexamethasone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hartford HealthCare Cancer Institute at The Hospital of Central Connecticut, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".